Literature DB >> 18180411

Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample.

Su-Ting T Li1, Robert L Gates.   

Abstract

OBJECTIVE: To determine whether primary operative management (decortication within the first 2 days of hospitalization) decreases hospital length of stay (LOS) and total charges in children with empyema.
DESIGN: Retrospective cohort study.
SETTING: Nationally representative Kids' Inpatient Database for 2003. PARTICIPANTS: Children and adolescents aged 0 to 18 years (hereinafter referred to as children) with empyema. MAIN OUTCOME MEASURES: Hospital LOS and total charges.
RESULTS: A total of 1173 children with empyema were identified. Compared with children treated with primary nonoperative management, children treated with primary operative management had a shorter hospital LOS by 4.3 (95% confidence interval [CI], 2.3-6.4) days and lower total hospital charges by $21,179.80 (95% CI, -$34,111.12 to -$8248.48) and were less likely to be transferred to another short-term hospital (0% vs 13.3%). In addition, children with primary operative management were less likely to have therapeutic failure (odds ratio, 0.08 [95% CI, 0.04-0.15]). There was no difference in complications between the 2 groups (odds ratio, 1.01 [95% CI, 0.59-1.74]).
CONCLUSION: Primary operative management is associated with decreased LOS, hospital charges, and likelihood of transfer to another short-term hospital, compared with nonoperative management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180411     DOI: 10.1001/archpediatrics.2007.10

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  12 in total

1.  Minimally invasive surgery.

Authors:  Amar Shah; Anirudh Shah
Journal:  Indian J Pediatr       Date:  2008-09       Impact factor: 1.967

2.  Paediatric complicated pneumonia: Diagnosis and management of empyema.

Authors:  Tk Chibuk; E Cohen; Jl Robinson; S Mahant; Ds Hartfield
Journal:  Paediatr Child Health       Date:  2011-08       Impact factor: 2.253

3.  Emergence of parapneumonic empyema in the USA.

Authors:  Carlos G Grijalva; Yuwei Zhu; J Pekka Nuorti; Marie R Griffin
Journal:  Thorax       Date:  2011-05-26       Impact factor: 9.139

4.  Complications and treatment failures of video-assisted thoracoscopic debridement for pediatric empyema.

Authors:  Andreas H Meier; Clayton B Hess; Robert E Cilley
Journal:  Pediatr Surg Int       Date:  2010-02-11       Impact factor: 1.827

5.  Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood.

Authors:  Samir S Shah; Matthew Hall; Jason G Newland; Thomas V Brogan; Reid W D Farris; Derek J Williams; Gitte Larsen; Bryan R Fine; James E Levin; Jeffrey S Wagener; Patrick H Conway; Angela L Myers
Journal:  J Hosp Med       Date:  2011-03-03       Impact factor: 2.960

6.  Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia.

Authors:  Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

7.  Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement.

Authors:  Samir S Shah; Thomas R Ten Have; Joshua P Metlay
Journal:  Pediatr Pulmonol       Date:  2010-01

8.  VATS: first step in the parapneumonic empyema*.

Authors:  G Di Napoli; M Ronzini; G Paradies
Journal:  G Chir       Date:  2014 May-Jun

9.  Initial treatment of septated parapneumonic empyema with drainage plus fibrinolytic agents is equally effective as video-assisted thoracoscopic surgery, and is suitable as first-line therapy.

Authors:  Chiyoe Shirota; Hiroo Uchida
Journal:  Transl Pediatr       Date:  2015-01

10.  Surgical management of complicated parapneumonic pleural effusion in children.

Authors:  Anca Budusan; Ioan Paraian; Doina Zamora
Journal:  Clujul Med       Date:  2013-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.